AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 239 filers reported holding AMICUS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $470,000 | -45.7% | 45,000 | -44.1% | 0.75% | -41.7% |
| Q2 2022 | $865,000 | -8.7% | 80,500 | -19.5% | 1.28% | +42.9% |
| Q1 2022 | $947,000 | -65.4% | 100,000 | -57.8% | 0.90% | -38.4% |
| Q4 2021 | $2,737,000 | +0.6% | 237,000 | -16.8% | 1.46% | +21.6% |
| Q3 2021 | $2,722,000 | -44.2% | 285,000 | -43.7% | 1.20% | -48.1% |
| Q2 2021 | $4,878,000 | +5.4% | 506,000 | +8.0% | 2.31% | +30.5% |
| Q1 2021 | $4,629,000 | +135.8% | 468,600 | +451.3% | 1.77% | +88.4% |
| Q4 2020 | $1,963,000 | – | 85,000 | – | 0.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |